Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Organizational Components

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

ONDQA Staff Presentations


This page lists selected presentations in reverse chronological order.  The text in the "Title" column is linked to the presentation.

 

Date

Title

Occasion/Speaker

     
November, 2004 Comparability Protocols: FDA Perspective [HTML] or [PPT] 2004 AAPS Annual Meeting/Stephen Moore
November, 2002 Post Approval Changes for Bulk Drug Manufacturing — Status Report [HTML] or [PPT] Nov 2002 AAPS Annual Meeting /John Smith
June 2002 HOT ISSUES Encountered While Drafting the FDA Drug Substance Guidance [HTML] or [PPT] June 2002 DIA Annual Meeting in Chicago/John Smith
November, 2001 Pharmaceutical Drug Packaging The Society of the Plastics Industry Inc., Charleston, SC/ Donald Klein
October, 2001 1987 Drug Substance Guideline Revision DIA Conference, Washington DC/ John Smith
May, 2001 Stability Data File DIA Data Standards, Washington, DC/  
Jon Clark
January, 2001 Presentations and software demonstrations as follows: Electronic IND Public Meeting, Rockville MD/
Life Cycle Management Steven Koepke
CTOC Model Slides Jon Clark

Three Hyperlinks:
FDA Position Statement
CTOC XML Tool Download
Link Validation Tool

Naiqi Ya
October, 2000 Product Quality, and Chemistry, Manufacturing and Controls Reviews AAPS Annual Meeting and Exposition, Indianapolis IN /Hasmukh Patel
October, 2000 Seven sets of slides were presented as follows:  PhRMA/ONDC Dialog Session, Rockville MD/
Risk-Based CMC Review: Yuan-yuan Chiu
ICH Guidances Implementation Consistency: Chuck Hoiberg
Guidance and Regs Status: Hasmukh Patel
Electronic CMC Submissions: Jon Clark
Division vs. Field Responsibilities: Chuck Hoiberg
Drug Supply Shortage Group: Eric Duffy
Pre-NDA Meetings: Steve Koepke
September, 2000 Role of ONDC in CDER's Mission OTCOM Reviewer Training, Rockville, MD/
Shelly Markofsky,
Hasmukh Patel,
Bonnie Dunn
June, 2000 Packaging Post Approval Changes (PACPAC) AMPAC/PACPAC Workshop, Crystal City, VA /Don Klein
May, 2000 History of SUPAC

Comparison of SUPAC IR,MR,SS

FDA/ISPE SUPAC Idustry Exchange, Providence, RI /Bonnie Dunn
May, 2000 Pharmaceutical Solids SSCI Solids Course, Crystal City, VA /Chuck Hoiberg
January, 2000 ICH Update - Quality Class Conference,  San Francisco /Yuan-yuan Chiu
October, 1999 Container/Closure
Guidance,
four  presentations:
Guidance Introduction
Guidance Overview
Type III DMF
Bulk Containers
FDA/Industry Container Closure Guidance Training Session, Rockville/
John Smith
Donald Klein
James Vidra
Melissa Maust
October, 1999 FDA Perspectives on Manufacture of Single Enantiomer Drugs "45th International Conference on Analytical Sciences and Spectroscopy" Vancouver, Canada/Steve Miller
September, 1999 Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics 1999 PDA FDA Joint Conference &Courses:  New FDA Packaging Guidelines/Donald Klein
August, 1999 The Impact of Polymorphism on Drug Development:
A Regulator's Viewpoint
  Separate Text Notes: MSWord

XVIIIth Congress of the International Union of Crystallography at Glasgow, Scotland/Wilson DeCamp

August, 1999 Quality Control and Quality Assurance of Botanicals Complementary and Alternative Medicine in Chronic Liver Disease, NIH, Rockville /Yuan-yuan Chiu
July, 1999 Regulatory Issues in the Photostability of Topical Drug Products Annual Meeting, American Society of Photobiology, Washington DC/William Timmer
July, 1999 CMC Electronic Submissions DIA Annual Meeting, Baltimore/Jon Clark


Back Back to ONDC Home Page


FDA/Center for Drug Evaluation and Research
Last Updated: January 19, 2006
Originator: OPS/ONDC
HTML by PKS;CA